Concepedia

Publication | Closed Access

A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience.

81

Citations

0

References

2014

Year

Charlotte Benson, Joanna Vitfell-Rasmussen, Marco Maruzzo, Cyril Fisher, Nina Tunariu, Scott C. Mitchell, Omar Al‐Muderis, Khin Thway, James Larkin, Ian Judson
PubMed

Abstract

Our study confirms that mTOR inhibition with sirolimus/temsirolimus is well-tolerated with good radiological responses, albeit short-lived, and supports its use in PEComas.